Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

GlaxoSmithKline LLC recalls ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
Products
  • ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60
Where it was sold

Distributed Nationwide in the USA and Puerto Rico.

Nationwide

Units affected
67,508 inhalers
About this recall
ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters total), Rx Only, Manufactured by GlaxoSmithKline Durham, NC 27701. NDC 0173-0869-10